Literature DB >> 3196881

Function of reticuloendothelial system in splenectomised thalassemics.

A Germenis1, P Dimitriou, H Vrettou, C Politi, T H Karpathios, S E Antipas.   

Abstract

The activity of reticuloendothelial system (RES) was estimated in 19 patients with beta-thalassemia major, 20 +/- 4 years old, who had undergone successful splenectomy 6 +/- 5 years previously. The kinetics of 125I denatured human serum albumin in low and large doses was applied for this purpose and the parameters derived (effective RES blood flow-ERBF- and maximum phagocytic capacity-PCmax) were compared to those of nonsplenectomized thalassemics, detected in previous works, as well as to those of 13 healthy controls. In splenectomised thalassemics both parameters of RES activity were found significantly lower than those of nonsplenectomized patients (p less than 0.001). Compared to those of healthy controls, PCmax of splenectomised thalassemics was found not to be significantly different, while ERBF was significantly lower (p less than 0.001). No correlation was noted between the above parameters of RES function and the age of the patients, the age at which splenectomy was performed, the time lapsed since the operation, the amount of blood transfused to the patients after splenectomy or their serum ferritin levels. A pilot study performed in 6 out of the 19 splenectomised patients did not reveal any effect of blood transfusion on RES function parameters, by contrast to observations in nonsplenectomized thalassemics. The results of this study suggest that in splenectomised thalassemics the remaining RES reacts to the continuing hemolytic stimulus in a manner different than that of splenic RES of nonsplenectomized patients and account for, at least in part, the predisposition of the former group to infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196881     DOI: 10.1007/bf00320359

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  12 in total

1.  Immunogenetic factors in thalassemia and hepatitis B infection. A multicentre study.

Authors:  M S Schanfield; G Scalise; I Economidou; C B Modell; C Bate; A J Zuckerman
Journal:  Dev Biol Stand       Date:  1975

Review 2.  Malign effects of splenectomy--the place of conservative treatment.

Authors:  N Werbin; K Lodha
Journal:  Postgrad Med J       Date:  1982-02       Impact factor: 2.401

3.  Immune status of Greek patients with beta-thalassemia major negative for anti-HIV.

Authors:  H Choremi; E Sidiri; K Psarra; J Economidou; P Georgiopoulou; C Politi; A Roumeliotou; G Papaevangelou
Journal:  Blut       Date:  1987-05

4.  Deficient activity of the alternative pathway of complement in beta thalassemia major.

Authors:  J M Corry; W C Marshall; L A Guthrie; A G Peerless; R B Johnston
Journal:  Am J Dis Child       Date:  1981-06

5.  Plasma fibronectin (Fn) study in homozygous beta-thalassemia: relation to splenectomy and transfusion.

Authors:  A Germenis; G Peppas; C Politi; A Fertakis
Journal:  Blut       Date:  1984-08

6.  Spleen size changes in children with homozygous beta-thalassaemia in relation to blood transfusion.

Authors:  T Karpathios; A Antypas; P Dimitiriou; P Nicolaidou; A Fretzayas; T Thomaidis; N Matsaniotis
Journal:  Scand J Haematol       Date:  1982-03

7.  RES phagocytosis in children with homozygous beta-thalassemia in relation to blood transfusion.

Authors:  P Dimitriou; J Giamouris; P Nicolaidou; S E Antipas; A Fretzayas; T Messaropoulos; T Karpathios
Journal:  Scand J Haematol       Date:  1986-11

8.  Effect of erythrocyte stroma on reticuloendothelial system phagocytic function.

Authors:  D J Loegering; J E Kaplan; G J Grover
Journal:  J Lab Clin Med       Date:  1983-08

9.  Effective RES blood flow changes in children with homozygous beta-thalassemia in relation to blood transfusion.

Authors:  T H Karpathios; P Dimitriou; J Giamouris; P Nicolaidou; S E Antipas; N Matsaniotis
Journal:  Eur J Nucl Med       Date:  1983

10.  Colloid clearance rate changes in children with homozygous-beta-thalassemia in relation to blood transfusion.

Authors:  P A Dimitriou; T E Karpathios; S E Antipas; A M Fretzayias; A G Kasfiki; K G Melissinos; N S Matsaniotis
Journal:  Eur J Nucl Med       Date:  1980-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.